Listeria-based GVAX immunotherapy

· Aduro Biotech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Listeria-based GVAX immunotherapy, covering 2018-05-08 to 2018-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer [Phase 2]